Healthy high growth potential
Results
6
Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.
6 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
CAMX | SEK 625.50 | -0.9% | -11.1% | SEK 37.2b | SEK 776.75 | 54.9 | 34.7% | n/a | ||
BONEX | SEK 221.00 | 5.9% | -34.3% | SEK 14.6b | SEK 357.25 | 68.0 | 32.8% | n/a | ||
BIOA B | SEK 324.40 | 5.3% | 54.9% | SEK 28.8b | SEK 316.75 | 135.0 | 64.4% | 0.6% | ||
GENO | SEK 19.60 | 0.7% | -28.1% | SEK 1.3b | SEK 33.00 | 64.5 | 44.2% | n/a | ||
MOB | SEK 9.77 | 4.0% | 8.0% | SEK 459.2m | SEK 14.00 | 31.5 | 100.9% | n/a | ||
ALZCUR | SEK 6.14 | -7.0% | 100.0% | SEK 846.7m | SEK 14.30 | 75.4 | 75.8% | n/a |
Page 1 of 1